Key result
Flu vaccination is well tolerated in MS patients with no increase in relapses versus unvaccinated controls.
Why the study?
The Italian Medicines Agency emphasized the importance of flu vaccination for patients with multiple sclerosis, prompting an assessment of flu vaccine safety regarding short- and long-term adverse events following immunization.
Does flu vaccination cause adverse events or MS relapse in patients with Multiple Sclerosis?
Observational (n=194)
No
Does flu vaccination cause adverse events or MS relapse in patients with Multiple Sclerosis?
Flu vaccines are well tolerated in MS patients with no increased risk of MS relapse or infections compared to unvaccinated patients.
No takes yet. Share an insight, caveat, or question.
Flu vaccination appears tolerable in MS; supports safety counseling but leaves open need for larger prospective confirmation.
Maniscalco et al. (2022) conducted an observational in Multiple Sclerosis (n=194). Flu vaccines vs. Unvaccinated patients was evaluated on occurrence of short-term and long-term Adverse Events Following Immunization (AEFIs). Flu vaccination was well tolerated in multiple sclerosis patients, with 33.8% experiencing non-serious short-term adverse events and no significant difference in MS relapses versus unvaccinated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: